{"id":"https://openalex.org/W1997949901","doi":"https://doi.org/10.1021/jm010440g","title":"Orally-Effective, Long-Acting Sorbitol Dehydrogenase Inhibitors: Synthesis, Structure\u2212Activity Relationships, and in Vivo Evaluations of Novel Heterocycle-Substituted Piperazino-Pyrimidines","display_name":"Orally-Effective, Long-Acting Sorbitol Dehydrogenase Inhibitors: Synthesis, Structure\u2212Activity Relationships, and in Vivo Evaluations of Novel Heterocycle-Substituted Piperazino-Pyrimidines","publication_year":2001,"publication_date":"2001-12-20","ids":{"openalex":"https://openalex.org/W1997949901","doi":"https://doi.org/10.1021/jm010440g","mag":"1997949901","pmid":"https://pubmed.ncbi.nlm.nih.gov/11784155"},"language":"en","primary_location":{"id":"doi:10.1021/jm010440g","doi":"https://doi.org/10.1021/jm010440g","is_oa":false,"landing_page_url":"https://doi.org/10.1021/jm010440g","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5082045002","display_name":"Margaret Y. Chu\u2010Moyer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Margaret Y. Chu-Moyer","raw_affiliation_strings":["Departments of Cardiovascular and Metabolic Disease and Drug Metabolism Development, Pfizer Global Research and Development, Groton Laboratories MS 8220-3095, Eastern Point Road, Groton, Connecticut 06340"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Cardiovascular and Metabolic Disease and Drug Metabolism Development, Pfizer Global Research and Development, Groton Laboratories MS 8220-3095, Eastern Point Road, Groton, Connecticut 06340","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":null,"display_name":"William E. Ballinger","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"William E. Ballinger","raw_affiliation_strings":["Departments of Cardiovascular and Metabolic Disease and Drug Metabolism Development, Pfizer Global Research and Development, Groton Laboratories MS 8220-3095, Eastern Point Road, Groton, Connecticut 06340"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Cardiovascular and Metabolic Disease and Drug Metabolism Development, Pfizer Global Research and Development, Groton Laboratories MS 8220-3095, Eastern Point Road, Groton, Connecticut 06340","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031878968","display_name":"David A. Beebe","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David A. Beebe","raw_affiliation_strings":["Departments of Cardiovascular and Metabolic Disease and Drug Metabolism Development, Pfizer Global Research and Development, Groton Laboratories MS 8220-3095, Eastern Point Road, Groton, Connecticut 06340"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Cardiovascular and Metabolic Disease and Drug Metabolism Development, Pfizer Global Research and Development, Groton Laboratories MS 8220-3095, Eastern Point Road, Groton, Connecticut 06340","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Richard Berger","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard Berger","raw_affiliation_strings":["Departments of Cardiovascular and Metabolic Disease and Drug Metabolism Development, Pfizer Global Research and Development, Groton Laboratories MS 8220-3095, Eastern Point Road, Groton, Connecticut 06340"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Cardiovascular and Metabolic Disease and Drug Metabolism Development, Pfizer Global Research and Development, Groton Laboratories MS 8220-3095, Eastern Point Road, Groton, Connecticut 06340","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035217846","display_name":"James B. Coutcher","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James B. Coutcher","raw_affiliation_strings":["Departments of Cardiovascular and Metabolic Disease and Drug Metabolism Development, Pfizer Global Research and Development, Groton Laboratories MS 8220-3095, Eastern Point Road, Groton, Connecticut 06340"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Cardiovascular and Metabolic Disease and Drug Metabolism Development, Pfizer Global Research and Development, Groton Laboratories MS 8220-3095, Eastern Point Road, Groton, Connecticut 06340","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060265604","display_name":"Wesley W. Day","orcid":"https://orcid.org/0000-0002-6451-8752","observed_orcids":["https://orcid.org/0000-0002-6451-8752"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Wesley W. Day","raw_affiliation_strings":["Departments of Cardiovascular and Metabolic Disease and Drug Metabolism Development, Pfizer Global Research and Development, Groton Laboratories MS 8220-3095, Eastern Point Road, Groton, Connecticut 06340"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Cardiovascular and Metabolic Disease and Drug Metabolism Development, Pfizer Global Research and Development, Groton Laboratories MS 8220-3095, Eastern Point Road, Groton, Connecticut 06340","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100785962","display_name":"Jiancheng Li","orcid":"https://orcid.org/0000-0003-2148-9872","observed_orcids":["https://orcid.org/0000-0003-2148-9872"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jiancheng Li","raw_affiliation_strings":["Departments of Cardiovascular and Metabolic Disease and Drug Metabolism Development, Pfizer Global Research and Development, Groton Laboratories MS 8220-3095, Eastern Point Road, Groton, Connecticut 06340"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Cardiovascular and Metabolic Disease and Drug Metabolism Development, Pfizer Global Research and Development, Groton Laboratories MS 8220-3095, Eastern Point Road, Groton, Connecticut 06340","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074782636","display_name":"Banavara L. Mylari","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Banavara L. Mylari","raw_affiliation_strings":["Departments of Cardiovascular and Metabolic Disease and Drug Metabolism Development, Pfizer Global Research and Development, Groton Laboratories MS 8220-3095, Eastern Point Road, Groton, Connecticut 06340"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Cardiovascular and Metabolic Disease and Drug Metabolism Development, Pfizer Global Research and Development, Groton Laboratories MS 8220-3095, Eastern Point Road, Groton, Connecticut 06340","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014233833","display_name":"Peter J. Oates","orcid":"https://orcid.org/0000-0002-7951-7197","observed_orcids":["https://orcid.org/0000-0002-7951-7197"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Peter J. Oates","raw_affiliation_strings":["Departments of Cardiovascular and Metabolic Disease and Drug Metabolism Development, Pfizer Global Research and Development, Groton Laboratories MS 8220-3095, Eastern Point Road, Groton, Connecticut 06340"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Cardiovascular and Metabolic Disease and Drug Metabolism Development, Pfizer Global Research and Development, Groton Laboratories MS 8220-3095, Eastern Point Road, Groton, Connecticut 06340","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5074934393","display_name":"R. Matthew Weekly","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R. Matthew Weekly","raw_affiliation_strings":["Departments of Cardiovascular and Metabolic Disease and Drug Metabolism Development, Pfizer Global Research and Development, Groton Laboratories MS 8220-3095, Eastern Point Road, Groton, Connecticut 06340"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Cardiovascular and Metabolic Disease and Drug Metabolism Development, Pfizer Global Research and Development, Groton Laboratories MS 8220-3095, Eastern Point Road, Groton, Connecticut 06340","institution_ids":["https://openalex.org/I180857899"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5082045002"],"corresponding_institution_ids":["https://openalex.org/I180857899"],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":null,"fwci":0.6819,"has_fulltext":false,"cited_by_count":47,"citation_normalized_percentile":{"value":0.61655012,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"45","issue":"2","first_page":"511","last_page":"528"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12533","display_name":"Aldose Reductase and Taurine","score":0.6553000211715698,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12533","display_name":"Aldose Reductase and Taurine","score":0.6553000211715698,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.18790000677108765,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10835","display_name":"Carbohydrate Chemistry and Synthesis","score":0.0357000008225441,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.8330000042915344},{"id":"https://openalex.org/keywords/oral-bioavailability","display_name":"oral bioavailability","score":0.7110000252723694},{"id":"https://openalex.org/keywords/circulating-half-life","display_name":"serum half-life","score":0.8629999756813049},{"id":"https://openalex.org/keywords/diabetic-neuropathy","display_name":"diabetic neuropathy","score":0.7639999985694885},{"id":"https://openalex.org/keywords/chronic-diabetes","display_name":"chronic diabetes","score":0.6639999747276306},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7310000061988831},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.8859999775886536}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.8615763783454895},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.8585315942764282},{"id":"https://openalex.org/C57992300","wikidata":"https://www.wikidata.org/wiki/Q2066956","display_name":"Potency","level":3,"score":0.8237596750259399},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.7338424324989319},{"id":"https://openalex.org/C2777905771","wikidata":"https://www.wikidata.org/wiki/Q2303179","display_name":"Sorbitol dehydrogenase","level":3,"score":0.6990283131599426},{"id":"https://openalex.org/C2776779347","wikidata":"https://www.wikidata.org/wiki/Q245280","display_name":"Sorbitol","level":2,"score":0.6178867220878601},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.5826675295829773},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.52470862865448},{"id":"https://openalex.org/C2777056448","wikidata":"https://www.wikidata.org/wiki/Q285166","display_name":"Oral administration","level":2,"score":0.43733906745910645},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.3807286024093628},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.3351238965988159},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.0993373692035675},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002908","descriptor_name":"Chronic Disease","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003921","descriptor_name":"Diabetes Mellitus, Experimental","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D005632","descriptor_name":"Fructose","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D007064","descriptor_name":"L-Iditol 2-Dehydrogenase","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D012584","descriptor_name":"Sciatic Nerve","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D013237","descriptor_name":"Stereoisomerism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1021/jm010440g","doi":"https://doi.org/10.1021/jm010440g","is_oa":false,"landing_page_url":"https://doi.org/10.1021/jm010440g","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},{"id":"pmid:11784155","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11784155","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of medicinal chemistry","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8371999859809875}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":19,"referenced_works":["https://openalex.org/W1966944942","https://openalex.org/W1967818300","https://openalex.org/W1973924357","https://openalex.org/W2012373895","https://openalex.org/W2018412517","https://openalex.org/W2045780799","https://openalex.org/W2089329413","https://openalex.org/W2099852272","https://openalex.org/W2116727374","https://openalex.org/W2157346067","https://openalex.org/W2159614641","https://openalex.org/W2273544524","https://openalex.org/W2312687874","https://openalex.org/W2334672323","https://openalex.org/W2337738945","https://openalex.org/W2340948203","https://openalex.org/W2952693161","https://openalex.org/W2952870422","https://openalex.org/W4246874446"],"related_works":["https://openalex.org/W2046472075","https://openalex.org/W1966944942","https://openalex.org/W2005135273","https://openalex.org/W2429125944","https://openalex.org/W2951779410","https://openalex.org/W2143699553","https://openalex.org/W1965866394","https://openalex.org/W4229589323","https://openalex.org/W2949743040","https://openalex.org/W2022045204"],"abstract_inverted_index":{"Optimization":[0],"of":[1,14,28,37,83,89,103,118,127,148],"a":[2,26,35,115,132,145],"previously":[3],"disclosed":[4],"sorbitol":[5,119],"dehydrogenase":[6],"inhibitor":[7,117],"(SDI,":[8],"II)":[9],"for":[10,137],"potency":[11,66,99],"and":[12,47,59,111],"duration":[13],"action":[15],"was":[16,77,108],"achieved":[17,78],"by":[18],"replacing":[19],"the":[20,62,84,97],"metabolically":[21],"labile":[22],"N,N-dimethylsulfamoyl":[23],"group":[24],"with":[25,43,100,121],"variety":[27],"heterocycles.":[29],"Specifically,":[30],"this":[31,90],"effort":[32],"led":[33],"to":[34,113],"series":[36],"novel,":[38],"in":[39,49,52,64,67,131],"vitro":[40],"potent":[41],"SDIs":[42],"longer":[44],"serum":[45],"half-lives":[46],"acceptable":[48],"vivo":[50,65],"activity":[51],"acutely":[53],"diabetic":[54,69,134],"rats":[55],"(e.g.,":[56],"62,":[57],"67,":[58],"69).":[60],"However,":[61],"desired":[63],"chronically":[68,133],"rats,":[70],"ED(90)":[71,101],"<":[72],"or":[73],"=":[74],"5":[75],"mg/kg/day,":[76],"only":[79],"through":[80],"further":[81,109],"modification":[82],"piperazine":[85],"linker.":[86],"Several":[87],"members":[88],"family,":[91],"including":[92],"86,":[93],"showed":[94],"better":[95],"than":[96],"targeted":[98],"values":[102],"1-2":[104],"mg/kg/day.":[105,150],"Compound":[106],"86":[107],"profiled":[110],"found":[112],"be":[114],"selective":[116],"dehydrogenase,":[120],"excellent":[122],"pharmacodynamic/pharmacokinetic":[123],"properties,":[124],"demonstrating":[125],"normalization":[126],"sciatic":[128],"nerve":[129],"fructose":[130],"rat":[135],"model":[136],"approximately":[138],"17":[139],"h,":[140],"when":[141],"administered":[142],"orally":[143],"at":[144],"single":[146],"dose":[147],"2":[149]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}